Digital & Innovation
Purposeful innovation a must in enhancing customer experience, says AbbVie’s Strategy and Innovation leader
Digital & Innovation: Through the recent years of unprecedented global disruption and uncertainty, leaders have taken their commitment to innovation to a whole new level. Organisations that prioritise growth and innovation during crises tend to leap ahead of competitors that retrench.
AbbVie ANZ’s commitment to innovation has been amplified by the company’s investment in a unique role that does not exist in most other pharma and medtech organisations.
Mahesh Malalage, Head of Strategy and Innovation at AbbVie ANZ joined Health Industry Hub to discuss how innovation has evolved, the business drivers that are leading organisations to invest in innovation and key gaps in innovation that need to be addressed in the current environment.
Mahesh reflected on how to build an organisational culture around innovation and the levers for success in the new hybrid working ecosystem. He shared what best practice looks like when thinking about purposeful innovation to enhance customer experience.
News & Trends - MedTech & Diagnostics
Government faces scrutiny for inaction in private hospital sector despite Health Check warnings
Shadow Health Minister Senator Anne Ruston questioned the Department of Health’s commitment to addressing critical issues in the private hospital […]
MoreNews & Trends - MedTech & Diagnostics
Australia lags behind in funding pharmacogenomic testing: Pathologists urge action
Diagnostics & MedTech News: The call for urgent action to improve access to pharmacogenomic testing across Australia comes as demand […]
MoreNews & Trends - Pharmaceuticals
Australia’s first Cholesterol Awareness Week launched to tackle nation’s ‘silent disease’
Pharma News: Leading heart charities have come together to launch the nation’s first Cholesterol Awareness Week (11-17 November), aiming to […]
More